Objective: To support decision making on how to best redesign chronic care by studying the heterogeneity in effectiveness across chronic care management evaluations for heart failure.
INTRODUCTION
Heart failure poses significant challenges to health care systems. Health care demands as well as health care costs are likely to rise (Lee et al. 2004; Liao, Allen, and Whellan 2008) , since the prevalence of heart failure is expected to increase substantially due to ageing and increased survival (Cowie et al. 2002; Levy et al. 2002; Najafi, Jamrozik, and Dobson 2009) . Moreover, there is a considerable gap between appropriate care for chronic conditions and the care actually received.
Finally, there is an increasing need for more patient centred care (Bosch et al. 2009; Fonarow 2006; McGlynn 2003) .
To address these challenges (Bodenheimer, and Fernandez 2005; IOM 2001 ), various approaches have been proposed to improve the care for patients with heart failure. Perhaps best known are the concept of disease management and the chronic care model (CCM), while case management, integrated care, and care coordination are also often mentioned in relation to chronic care management (Gress et al. 2009 ).
The CCM is widely adopted as an evidence-based tool to improve chronic care (Busse et al. 2010; Coleman et al. 2009; Wagner et al. 2001 ).
Notwithstanding the awareness among policy makers, healthcare professionals and patients of the importance of chronic care management, coming to strong conclusions regarding the effectiveness of chronic care management interventions has been limited. Substantial heterogeneity between study outcomes -the variation in effectiveness between studies is higher than is to be expected by chance alone -limits insight into the effectiveness of chronic care management (Clark, Savard, and Thompson 2009; Coleman et al. 2009; Mattke, Seid, and Ma 2007) . This statistical heterogeneity is not only caused by clinical diversity (e.g. differences in interventions, like type and number of included CCM components, and outcomes studied), but also by methodological diversity (e.g. differences in length of follow-up and study design).
Insight into heterogeneity in effectiveness is needed to support the understanding of and decision making on chronic care management strategies. Some reviews tried to address the heterogeneity in outcomes by subgroup analysis (Gonseth et al. 2004; Kim, and Soeken 2005; Roccaforte et al. 2005; Taylor et al. 2005 ).
However, meta-regression analyses are needed to determine whether the differences between subgroups are stronger than is to be expected by chance alone. Although meta-regression analysis is a more promising tool to identify the characteristics of programs that predict better outcomes (Clark et al., 2009) , this has only been performed once restricted to randomized clinical trials (Gohler et al. 2006 ). This paper presents an overview of reviews and studies with the aim to provide insight into the currently available evidence of chronic care management interventions, taking the clinical and methodological variation into account. In addition, meta-regression analyses were performed to gain insight in three potential causes of heterogeneity. It was hypothesized that differences in outcomes between the studies could be explained by differences in the following factors: 1) methodological quality of the studies; 2) length of follow-up; and, 3) number of CCM components addressed by the interventions. This paper aims to support the understanding of and decision making on chronic care management strategies for heart failure by reporting on the effect and their factors explaining the heterogeneity in effectiveness between chronic care management interventions.
METHODS

Literature search
Electronic database searches for English language systematic reviews and metaanalyses published between 1995 and 2009 were conducted in Medline and CINAHL, using the following Medical Subject Headings (MeSH): patient care team, patient care planning, primary nursing care, case management, critical pathways, primary healthcare, continuity of patient care, guidelines, practice guideline, disease management, comprehensive healthcare, and ambulatory care. These were combined with the MeSH term heart failure. In addition, disease state management, disease management, integrated care, coordinated care, and shared care in combination with heart failure were searched as text words in title and/or abstract words.
Study inclusion and data extraction
Systematic reviews and primary papers were included if they focused on: 1) heart failure as the main condition of interest; 2) adult patients as the main receivers of the interventions; and 3) interventions addressing at least two CCM components (Wagner et al. 2001) . Studies published before 1995 were excluded; around that year chronic care management strategies became an important issue (Norris et al. 2003) . Case reports and expert opinions were also excluded. Two reviewers (HD and LS) independently extracted data, using separate data entry forms for systematic reviews and primary papers. Disagreements were resolved by consensus with the third author (LL).
Assessing the sources of heterogeneity
Substantial heterogeneity in effectiveness across chronic care management interventions is likely, i.e. differences in study outcomes are probably greater than is to be expected by chance alone (Clark et al. 2009; Coleman et al. 2009 ). We identified three factors which may explain the heterogeneity in effectiveness: study quality, length of follow-up, and the number of CCM components.
First, study quality is expected to explain part of the heterogeneity in outcomes, but this has not yet been tested by means of meta-regression analyses (Gonseth et al. 2004; Kim, and Soeken 2005; Roccaforte et al. 2005; Taylor et al. 2005 ). We used the validated HTA-DM instrument to classify the primary studies as demonstrating either low (<50 points), moderate (50 to 69 points), or high quality (70 to 100 points) (Steuten et al. 2004 ). The HTA-DM instrument reliably measures the methodological quality of health technology assessments of disease management (Steuten et al. 2004 ). We used this instrument to determine to what extent study quality explains the heterogeneity in results between studies.
Second, length of follow-up was assessed as chronic care management interventions require behavioural, organisational and cultural changes which tend to take considerable time to take effect (Grol et al. 2007 ). Length of follow-up equals the reported number of months of the follow-up period.
Third, the number of CCM components was taken into account as more comprehensive programs were expected to be more effective (Wagner et al. 2005 ).
The number of CCM components addressed by the chronic care management interventions was identified following the coding scheme of Zwar et al.: self management support (SMS) (i.e. supporting patients to manage their condition by routinely assessing progress, education, etc); delivery system design (DSD) (i.e. the organization of providing care such as planned visits, other roles/teams, etc.); decision support (DS) (i.e. integration of evidence based clinical guidelines into practice by reminder system, feedback system, etc); and clinical information systems (CIS) (i.e. information systems to capture and use critical information like reminders, feedback on performance, etc.) (Zwar et al. 2006) .
Data analyses
Data collected from reviews were descriptively analyzed and data gathered from primary studies were descriptively analyzed and meta-analyzed. The outcomes measured most frequently, i.e. hospitalization rate, mortality, and quality of life, were meta-analyzed. Review Manager (RevMan 5.0.2) was used to compute the pooled overall effects and the pooled effects for the subgroups of the three factors i.e. quality of study (poor, moderate, or good), length of follow-up (less than one year or longer), and number of components (two, three, or four). Pooled risk ratios for dichotomous outcomes were analyzed with the Mantel-Haenszel method using the random effect model (Lipsey, and Wilson 2001) . Pooled mean differences for continuous outcomes were analyzed with the random model of Dersimonian and Laird (Lipsey, and Wilson 2001) .
Meta-regression analysis was performed to determine to what extent the heterogeneity is explained by the quality of the studies, the length of follow-up, and the number of CCM components, if at least ten studies could be included in the analyses (The Cochrane Collaboration 2009). In contrast with the subgroup analyses, all factors were taken into account as continuous variables. The effect sizes of primary studies were weighted using the inverse variance weight formulas (Lipsey, and Wilson 2001) and imported together with the co-variates into the SAS statistical package (version 9.2) (van Houwelingen, Arends, and Stijnen 2002) . The extent to which the three factors explained the variance between studies was examined by fitting of univariable meta-regression models (Thompson, and Higgins 2002) . The relative decrease of the between-study variance in the univariable model compared to an intercept only model was interpreted as the percentage of heterogeneity explained.
[FIGURE 1]
RESULTS
Results of the search
Fifteen systematic reviews and 46 primary studies (reported in 47 papers) were included ( Figure 1) . A description of the included reviews is available online as are all the references of these papers (Appendix 1). The number of primary papers included in the reviews varied from 6 to 54. The included set of primary papers consists of 32 randomized controlled trials, 4 non-randomized controlled clinical trials, 9 beforeafter studies, and 1 chart review.
Findings from the systematic reviews
The definitions of chronic care management as well as the nature of the included interventions varied. Some interventions were purely physician driven, other were nurse-led; some were clinic-based, other involved home care, etc. (Appendix 1). A common aspect of the included interventions was a strong focus on reducing hospital admissions, and hence on (post)discharge planning and self-management. The reported outcome measures varied. Almost all reviews reported hospitalization, whereas other outcomes, like patient satisfaction and quality of life, were measured by less than half of the reviews.
Overall, the reviews showed positive effects, although with substantial heterogeneity between study outcomes. Most meta-analyses revealed a significant reduction on all-cause hospitalization (Gohler et al. 2006; Gonseth et al. 2004; Gwadry-Sridhar et al. 2004; McAlister et al. 2001; Phillips et al. 2004; Roccaforte et al. 2005; Taylor et al. 2005 ) with a relative risk reduction ranging from 12 to 25 per cent. Results on mortality were less convincing; only two reviews reported a significant positive effect (Gohler et al. 2006; Roccaforte et al. 2005) . Results on quality of life were inconclusive, as it was less frequently used as an outcome measure and only once meta-analyzed (Appendix 1).
Several meta-analyses included subgroup analyses to determine whether specific variables, like age or length of follow-up, were associated with the effectiveness of chronic care management interventions. To find out whether the differences between subgroups were stronger than was to be expected by chance alone, a meta-regression analysis should be performed. However, we found only one study that included a meta-regression analysis (Gohler et al. 2006 ). Since Gohler et al. limited this meta-regression analysis to RCT's, insight into the effect of the three selected factors, i.e. study quality, length of follow-up, and number of components, is limited.
Findings from the primary studies
Of the 46 included primary studies, 44% scored 'good' on methodological quality (Ansari et al. 2003; Atienza et al. 2004; Austin et al. 2005; Blue et al. 2001; Bouvy et al. 2003; Capomolla et al. 2002; DeBusk et al. 2004; Doughty et al. 2002; Ducharme et al. 2005; Dunagan et al. 2005; Ekman et al. 1998; Gattis et al. 1999; GESICA 2005; Harrison et al. 2002; Krumholz et al. 2002; Riegel et al. 2002; Stewart, and Horowitz 2002; Stewart, Marley, and Horowitz 1999; Stewart, Pearson, and Horowitz 1998; Stromberg et al. 2003) , 41% scored 'moderate' (Benatar et al. 2003; Bull, Hansen, and Gross 2000; Cline et al. 1998; Costantini et al. 2001; Heidenreich, Ruggerio, and Massie 1999; Hughes et al. 2000; Kasper et al. 2002; Laramee et al. 2003; McDonald et al. 2002; Naylor et al. 2004; Oddone et al. 1999; Pugh et al. 2001; Rich et al. 1995; Weinberger, Oddone, and Henderson 1996) , and 15% scored 'poor' (Akosah et al. 2002; Azevedo et al. 2002; Branch 1999; Rainville 1999; Rauh et al. 1999; Roglieri et al. 1997; Tsuyuki et al. 2004 ). Length of follow-up varied between three to 50 months; two studies reported more than one year (GESICA 2005; Stewart, and Horowitz 2002) . The numbers of studies addressing four, three, or two CCM components were eighteen, seventeen, and eleven studies, respectively. The component of chronic care management included most frequently was SMS (n=43), followed by DSD (n=38), CIS (n=37), and DS (n=27) ( Table 1) .
[TABLE 1]
Notwithstanding the differences in the operationalisation of the CCM components between studies, some general trends could be identified. SMS often consisted of patient education and telephone follow-up, DSD was often realized by the introduction of a specialized nurse and/or multidisciplinary team, CIS mainly consisted of telephone follow-up and DS of protocols for chronic care management.
Most studies were performed in primary and secondary care settings with about half of the studies starting after hospitalization. The study aims varied between improving medication prescription (e.g. appropriate beta-blocker prescription), medication adherence (e.g. beta-blocker use), and self-management (e.g. by providing education, self-management monitoring tools, exercise or diet advice), usually with a strong focus on reducing hospitalization.
Hospitalization
The measures of all-cause and HF hospital admission varied between the studies (e.g. at least one hospitalization, length of stay, and cumulative hospital days). The relative risk of at least one hospitalization for any cause was measured most frequently (n=27) (Atienza et al. 2004; Austin et al. 2005; Blue et al. 2001; Capomolla et al. 2002; Cline et al. 1998; DeBusk et al. 2004; Doughty et al. 2002; Ducharme et al. 2005; Dunagan et al. 2005; Ekman et al. 1998; Fonarow et al. 1997; GESICA 2005; Harrison et al. 2002; Hughes et al. 2000; Krumholz et al. 2002; Laramee et al. 2003; Naylor et al. 2004; Oddone et al. 1999; Pugh et al. 2001; Rich et al. 1995; Riegel et al. 2002; Shah et al. 1998; Stewart, and Horowitz 2002; Stewart et al. 1999; Stewart et al. 1998; Stromberg et al. 2003; Tsuyuki et al. 2004 ). The result of five studies were not included in the meta-analysis because of missing data (Krumholz et al. 2002; Shah et al. 1998; Stromberg et al. 2003) or because preliminary results were reported (we only included the last results of the same primary study) (Stewart et al. 1999; Stewart et al. 1998 ). In total, 22 studies were included in our meta-analysis on all-cause hospitalization (i.e. the number of patients with at least one all-cause hospitalization during the study period).
The pooled relative risk for all-cause hospitalization with chronic care management compared to the control intervention (mostly usual care) is 0.82 (95%-CI: 0.72-0.94; I 2 :84%). Subgroup analyses showed that studies of good methodological quality, with a follow-up period of at least one year, and studies reporting on interventions including three CCM components demonstrated a significant reduction in the number of patients with at least one all-cause hospitalization. The associations suggested by the subgroup analyses, like the positive association between the study quality and hospitalization, were tested by the metaregression analysis. Meta-regressions showed no significance of the three factors (p>0.50), which implies that these could not significantly explain the heterogeneity between the studies.
[TABLE 2] Mortality
Twenty-nine studies reporting on all-cause mortality were included in our metaanalysis (Akosah et al. 2002; Ansari et al. 2003; Atienza et al. 2004; Austin et al. 2005; Azevedo et al. 2002; Blue et al. 2001; Bouvy et al. 2003; Capomolla et al. 2002; Cline et al. 1998; DeBusk et al. 2004; Doughty et al. 2002; Ducharme et al. 2005; Dunagan et al. 2005; Ekman et al. 1998; Gattis et al. 1999; GESICA 2005; Kasper et al. 2002; Krumholz et al. 2002; Laramee et al. 2003; McDonald et al. 2002; Naylor et al. 2004; Oddone et al. 1999; Pugh et al. 2001; Rainville 1999; Rich et al. 1995; Stewart, and Horowitz 2002) . Overall, the pooled effect showed a significantly reduced relative risk of mortality (RR: 0.82; 95%-CI: 0.76-0.93; I 2 =0%). This implies that the chance to die during the follow-up period is reduced by 18% for patients receiving chronic care management.
Subgroup analyses showed that pooled effects for studies of a moderate quality, with a follow-up period of less than one year, or on three CCM components were not associated with a significant reduction of mortality (Table 2) . Metaregression analysis was used to determine whether the variables were associated with the effect, as no heterogeneity had to be explained (I 2 =0%). The meta-regression analysis showed that none of the variables were associated with the effect of chronic care management on mortality (p>0.05).
Quality of life
A variety of instruments was used to assess quality of life; the Minnesota Living with
Heart Failure (MLHF) questionnaire was used most frequently (n=14) (Atienza et al. of seven studies could be used (Austin et al. 2005; Benatar et al. 2003; Bouvy et al. 2003; Harrison et al. 2002; Holst et al. 2001; Naylor et al. 2004; Vavouranakis et al. 2003) , the remaining studies were excluded because of missing or skewed data.
( Atienza et al. 2004; Doughty et al. 2002; Ducharme et al. 2005; Dunagan et al. 2005; GESICA 2005; Kasper et al. 2002; Stewart et al. 1999) .
The meta-analysis demonstrated a significant improvement in quality of life of 7.14 points on the MLHF questionnaire (95% CI: -9.55--4.72). Subgroup analyses showed that the pooled effect of studies of a good quality, with a follow-up of less than one year, or on two or three components are significantly positive (Table 3 ). The heterogeneity between the studies in the subgroups is substantial (I 2 : 50%-90%) or considerable (I 2 > 75%). Meta-regression analysis could not be performed, as less than ten studies were available.
DISCUSSION
This systematic review showed that predominantly positive effects of chronic care management on clinical outcomes and health care consumption were reported by earlier reviews. Since size and significance of the effects vary due to considerable methodological and clinical heterogeneity between the reviews and their included studies, we performed a meta-regression analysis. The analysis showed a significant reduction of 18% in mortality, irrespective of the differences between the studies.
Furthermore, all-cause hospitalization and quality of life improved significantly, yet, with substantial heterogeneity between the studies which could not be explained by the quality of the studies, the length of follow-up, or the number of CCM components.
In addition to previously published reviews and studies, this review gives a comprehensive overview of previously published reviews and studies as well as a meta-regression analysis to explain the heterogeneity in outcomes. Although several reviews showed substantial differences in effect of chronic care management in subgroup meta-analyses for the quality of the studies, the direction of these differences was inconsistent between these reviews (Gonseth et al. 2004; Kim, and Soeken 2005; Roccaforte et al. 2005; Taylor et al. 2005) . None of these reviews had tested these associations suggested by the subgroup analysis with meta-regression analysis. Length of follow-up was studied in one meta-regression study only. In line with our results, Gohler et al. concluded that the effect on hospitalization remained when follow-up exceeded 3 months (Gohler et al. 2006) . In addition, these authors reported substantial effects on mortality due to diversity in length of follow-up, but significance of this explained heterogeneity was not reported (I 2 =34).
Our study aimed to find out whether the number of CCM components is positively associated with the effect of chronic care management, as comprehensive programs are expected to be more effective (Wagner et al. 2005) . We found no association between the number of components and the effect of chronic care management. However, other aspects of chronic care management interventions such as the integration of the components could also influence its effectiveness. Only one earlier review tried to explain heterogeneity by characteristics of chronic care management using meta-regression analysis. Gohler et al. found that the number of disciplines participating in the chronic care management interventions explained 60%
and 68% of the differences in effect size for mortality and hospitalization, respectively However, the influence of these characteristics must be interpreted with caution, as
the reported associations were not tested by meta-regression analyses.
Several limitations should be noted. First, even though an extensive search, based on the WHO's broad definition of chronic care management, was performed, we restricted the selection of our primary studies to published reviews. As a consequence, publication bias might have influenced the results, since more negative results and/or recently published studies were not included. However, this limitation will probably be limited, as the reviews included were peer reviewed and most of them included a publication bias analysis. Next, it is disputable whether the HTA-DM instrument -the only tested instrument for assessing the quality of complex interventions -properly measures the items that bias the effect of the interventions for heart failure, as it primarily focuses on the quality of reporting. Thirdly, we limited our analysis to three a-priori selected variables, that is the quality of the studies, the length of follow-up, and the number of CCM components. However, additional causes of heterogeneity are suggested and should be further studied. For instance, it was suggested that more recent studies showed a lower or no effectiveness of chronic care management interventions compared to earlier studies (Clark, and Thompson 2010) . Although additional analyses of our data set showed that year of study performance did not explain heterogeneity (data not shown), more recent studies should be included in future reviews since we only included studies from before 2006.
Besides year of study performance, other causes of heterogeneity should be studied such as contextual factors (e.g. professional's behaviour and unit of randomization) as well as characteristics of the intervention (e.g. combination of CCM components and intervention intensity). For example, almost all studies randomized on patient level except four studies, with contamination as well as limited insight in the contextual influences as a consequence. Furthermore, results of our subgroup analysis should be interpreted with caution, since these results are more than once based on less than 10 studies. Meta-regression analysis gave the opportunity to restrict this limitation for the length of follow-up and the study quality by including these variables as continuous variables. Finally, analyses of heterogeneity are limited by the quality and comprehensiveness of data reported in the primary studies. In particular, the care received by the control group, as well as results, such as p-values and standard deviations, were frequently not fully reported, and were therefore excluded from our meta-analysis.
As insight into the effect of chronic care management for heart failure is limited, more efforts should be made to assess the effectiveness. In particular, the follow-up period of chronic care management should be extended to enable the assessment of the effects after several years. Complex improvements, which need behavioral, organizational, and cultural changes, need time to take effect. Only
Stewart and colleagues had a follow-up period of more than 2 years, but the intervention in this study consisted of just one home visit (Stewart, and Horowitz 2002) . Furthermore, the influence of co-morbidity, which is highly prevalent in the heart failure population, (Bayliss, Ellis, and Steiner 2007; Marengoni et al. 2009) needs to be addressed, which the earlier primary studies failed to do. Moreover, effectiveness is most frequently assessed using clinical outcomes, like mortality and hospitalization, whereas more patient-centered outcomes are less frequently monitored. Meanwhile, a great variety of instruments that are sometimes difficult to compare is used to measure outcomes, like patient satisfaction and medication adherence, which complicates comparing or pooling of data.
Consequently, insight into the influence of other factors of chronic care management than those three studied in our review (study quality, length of followup, and number of CCM components) is needed. Although these three variables for 
Conclusion
Our meta-regression analysis showed that mortality is reduced by chronic care management, irrespective of the differences between the studies included.
Furthermore, the meta-regression analysis revealed that all-cause hospitalization and the quality of life could significantly be improved by chronic care management. The study quality, the length of follow-up, and the number of CCM components do not determine the effectiveness of chronic care management. Considering the unexplained heterogeneity in effectiveness across chronic care management interventions, more attention to the development and implementation of chronic care management is needed to support informed decision making about how to best redesign chronic care.
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